Created in 2007 (United States), Focal Therapeutics own 60 sister brands and 4472 competing brands. Focal Therapeutics is owned by Hologic, listed on the stock exchange of New York Focal Therapeutics belongs to the Medical Devices & Instruments business sector.
Share price and profitability of the share Hologic (Focal Therapeutics)
Buy Hologic share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Hologic
(Focal Therapeutics)
over 5 years*
USD 136.01
Stock market history Hologic (Focal Therapeutics)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
